Purpose We investigated the association between incidence of various cancers and four single nucleotide polymorphisms (SNPs), two each in two protein tyrosine phosphatase (PTP) genes, PTPRJ and PTPN13, by a casecontrol study conducted in Japan. Methods The study samples comprised 819 cancer-free controls and 569 cancer cases including lung, head and neck, colorectal, and esophageal cancers. Results Compared with the major homozygotes at the Arg326Gln SNP in PTPRJ, a likely homologue of the mouse SCC1 (susceptible to colon cancer), Arg/Gln or Gln/Gln genotypes exhibited an increased colorectal cancer risk with adjusted odds ratios (aOR) of 1.71 (P = 0.021) and 3.74 (P = 4.14 £ 10 ¡4 ), respectively. Increased risks were observed with one or more of the combination genotypes of Gln276Pro and Arg326Gln in PTPRJ for most cancer types (aOR range 10.13-55.08, Bonferronicorrected P = 0.0454-7.20 £ 10 ¡9 ). In the PTPN13, major homozygotes of Ile1522Met showed an increased risk for lung squamous cell carcinomas (aOR 1.86), compared to the heterozygotes. Increased risks were observed with at least one of the combination genotypes of the two SNPs, Ile1522Met and Tyr2081Asp, for all but esophageal cancer examined (aOR 3.36-13.75), compared with double heterozygotes. Moreover, these high risks were seen also when all cancer cases were combined (aOR 1.81-6.84). Conclusions PTPRJ and PTPN13 SNPs were found to inXuence susceptibility to a wide spectrum of cancers. Because allelic frequencies of these SNPs are relatively common in many ethnic groups, these Wndings are worthy of further study.
Introduction
The protein tyrosine phosphatase (PTP) family of proteins has been linked to many physiological phenomena, including regulation of cell growth and apoptosis (Andersen et al. 2001) . Deregulation of intracellular signaling pathways is closely related to cancer development and progression. PTP family proteins are implicated in these intracellular signaling pathways (Freiss and Vignon 2004) , generally through antagonizing eVects on protein-tyrosine phosphorylation, which is considered an enhancer of cell proliferation mediated by many oncogenic protein-tyrosine kinases.
The human receptor-type protein tyrosine phosphatase type J gene (PTPRJ) is a candidate human homologue of the mouse colon cancer susceptibility locus SCC1 (Ruivenkamp et al. 2002) . The protein has eight Wbronectin type III repeat domains in the extracellular portion, one transmembrane domain, and one phosphatase domain in the intracellular portion (Ostman et al. 1994 ). The PTPRJ product is ubiquitous in various tissues (Ruivenkamp et al. 2002) and the gene is expressed at high levels in hematopoietic cells (Ruivenkamp et al. 2002; de la Fuente-García et al. 1998 ). The PTPRJ locus on human chromosome 11p12 evidences frequent loss of heterozygosity (LOH) and missense mutations were identiWed in human colon, lung, and breast cancers (Ruivenkamp et al. 2002 (Ruivenkamp et al. , 2003 .
Non-receptor type protein-tyrosine phosphatase 13 (PTPN13) distributes in cytoplasm. It has a phosphatase domain in the C terminal portion and many non-catalytic domains, including Wve PDZ domains, an N-terminal KIND and FERM domain (Erdmann 2003) . These non-catalytic domains can bind to many proteins, including APC (Kachel et al. 2003) , and FAS (Ivanov et al. 2006) . It was recently reported that PTPN13 negatively regulates HER2/ ERBB2 malignant signaling (Zhu et al. 2008) . The second PDZ domain of PTPN13 can interact with FAS and inhibits apoptosis by abrogation of membrane traYcking of FAS (Ivanov et al. 2006) . Therefore, PTPN13 has been inferred to function as an apoptosis regulatory factor. In addition, it has been reported that PTPN13 is involved in regulation of cytokinesis by interacting with midbody, Rho-regulated protein kinase PRK2, and Rho-GAP protein (PARG) (Herrmann et al. 2003; Gross et al. 2001) . Thus, this phosphatase appears to modulate diverse cellular functions, probably in both positive and negative manners (Abaan and Toretsky 2008) .
Single nucleotide polymorphisms (SNPs) are the most popularly studied form of genetic polymorphism in genomic DNA. The majority of SNPs are silent and do not alter the function of proteins or gene expression (e.g., non-coding region SNP), but some SNPs (e.g., non-synonymous SNP) induce amino acid substitution in proteins or changes in gene expression (Erichsen and Chanock 2004) . Therefore, people inheriting non-synonymous SNPs in certain genes are at an increased risk of diseases such as cancer or diabetes. We know of the presence of some SNPs and mutations in PTPRJ (Ruivenkamp et al. 2002) and PTPN13 (Wang et al. 2004) , but evidence for an association of those SNPs with cancer risk remains elusive except in the cases of thyroid , breast (Lesueur et al. 2005) , and familial hepatoma (Yeh et al. 2006) .
In this study, we report divergent eVects of two missense SNPs in each of the PTPRJ and PTPN13 genes in terms of susceptibility to four major cancers in the Japanese population.
Materials and methods

Study subjects
Summary data on control subjects and cancer patients are shown in Table 1 . Cancer patients were treated at Okayama University Hospital (Okayama, Japan) between 1994 and 2007 and had cancer subtype diagnosed by pathologists. Subjects in control group I (n = 458) were selected at random from cancer-free outpatients at two hospitals around Okayama city using the same criteria as those for cancer patients. Subjects in control group II (n = 361) were selected at random from cancer-free healthy volunteers at a health care center in Okayama city very recently. Control groups I and II (n = 819) were considered to represent the Okayama area population, matching well the area distribution of the cases, and combined for use as the reference group. Each subject provided written informed consent before blood sampling. The Bioethics Committee of Okayama University Medical School approved this study.
DNA extraction
Genomic DNA was isolated from mononuclear cells of peripheral blood by standard methods of proteinase K digestion and phenol-chloroform extraction.
Genotype analysis by PCR-RFLP SNP genotypes on Arg326Gln SNP (rs1503185) of PTPRJ exon 6 and Tyr2081Asp (rs989902) of PTPN13 exon 39 were determined by polymerase chain reaction coupled with restriction fragment length polymorphism (PCR-RFLP). Both exons were ampliWed by PCR using rTaq DNA polymerase (TAKARA, Shiga, Japan) with the primer sets ( Table 2 ). The PCR conditions for PTPRJ exon 6 comprised a denaturing step of 94°C for 3 min, 35 cycles of 94°C for 30 s, 58°C for 1 min, and 72°C for 1 min, and a Wnal extension step at 72°C for 7 min. PTPN13 exon 39 was ampliWed similarly, but the annealing temperature was changed from 58 to 60°C. PCR products of PTPRJ exon 6 and PTPN13 exon 39 were digested by Ava I or Hinf I, respectively (New England Biolabs, Beverly, MA). Digested products were separated on 3% agarose gel containing ethidium bromide.
Genotype analysis by direct sequencing SNP genotypes of Gln276Pro (rs1566734) at PTPRJ exon 5 and Ile1522Met (rs2230600) at PTPN13 exon 29 can be genotyped by RFLP, but the digestion reactions are sometimes imperfect. We therefore determined these genotypes by direct sequence analyses. Both exons were ampliWed by PCR using rTaq DNA polymerase with the primer sets ( Table 2 ). The PCR conditions for PTPRJ exon 5 were the same as those for exon 6 as stated above. PTPN13 exon 29 was ampliWed similarly except that the annealing was done at 56°C. PCR products were treated with shrimp alkaline phosphatase and exonuclease 1, then sequencing reaction was carried out using a BigDye cycle sequencing kit (Applied Biosystems) with antisense primers for each exon. Genotypes were determined using an ABI3100 machine (Applied Biosystems).
Statistical analysis
The 2 test was used to compare genotype distributions of cancer patients and control subjects. Logistic regression was used to estimate the odds ratio (OR) of individuals with the genotype of each polymorphism compared with those having the major reference genotypes. ORs are expressed together with 95% conWdence interval (CI) and P value. A P value of <0.05 was considered to be statistically signiWcant. Multivariate logistic regression was used to adjust for age, gender, and smoking habit for lung adenocarcinoma (LAD), lung squamous cell carcinoma (LSQ), head and neck squamous cell carcinoma (HNSCC) and colorectal cancer (CRC). Esophageal cancer (ESCC) was adjusted for age, gender smoking habit and alcohol drinking habit. 2 tests and logistic regression analyses were carried out using SPSS software (Ver.12.0: SPSS Inc., Tokyo, Japan). Permutation tests with 10,000 reiterations were performed by the Haploview program (http://www.broad.mit.edu/mpg/ haploview/) (Barrett et al. 2005) . The Cochran-Armitage trend test and population attributable fraction (PAF) were calculated using software obtained from Tokyo University (http://func-gen.hgc.jp/index.html; in Japanese only). Results (P values) of multi-allelic analyses were corrected for multiple testing using the Bonferroni method. Results Table 1 shows the mean age, gender, smoking and drinking behavior of the study subjects.
Results of analyses on the associations between cancer and genotypes of PTPRJ and PTPN13 are shown in Tables 3 and 4 . Statistically signiWcant results are summarized in Tables 5 and   6 . The accordance with the Hardy-Weinberg equilibrium (HWE) of the allelic distribution of the SNPs of the PTP genes was assessed for the control subjects (780-819). The P values for HWE of the Gln276Pro, Arg326Gln of PTPRJ, Ile1522Met, and Tyr2081Asp of PTPN13 were 0.48, 0.92, 0.37, and 0.51, respectively. Thus, there is no signiWcant deviation from the equilibrium in the control population. Table 3 The association between the SNP genotypes of PTP genes and lung cancer risk All data were adjusted for age, gender, and smoking status * Statistically signiWcant data are shown in bold face; P value < 0.05 by 2 test PTPRJ genotypes and cancer risk
Single associations
The Arg326Gln, genotype frequencies in controls were 62% Arg/Arg, 33% Arg/Gln and 5% Gln/Gln, whereas in colorectal cancer (CRC) patients these were 45, 40 and 15%, respectively. Taking the Arg/Arg genotype as the reference, profoundly high risks of CRC were seen for the Arg/Gln (aOR = 1.71), Gln/Gln (aOR = 3.74), and Gln + (aOR = 1.95) genotypes. The permutation P value for this association was 1.0 £ 10 ¡4 . Gln/Gln and Gln+ genotype were signiWcant also at the 1% signiWcance level (99% CI). The PAF for the Gln+ genotype was 34% (Table 5 ), indicating that the Gln allele has a considerable impact on the incidence of CRC in the Japanese population. Among other cancers, lung squamous carcinoma (LSQ) cases with Gln/Gln genotypes showed a moderate risk (aOR = 2.75).
Associations with combined genotypes
When the genotypes of the two SNPs of PTPRJ were analyzed together, frequencies of the combined genotypes in controls were 61% Gln/Gln-Arg/Arg, 32% Gln/Pro-Arg/ Gln, and 7% consisting of all others (Table 3 ). The frequency of Gln/Gln-Arg/Gln genotype in controls was 1%, while in CRC cases it was 12%, resulting in a very high risk using the major genotype Gln/Gln-Arg/Arg as the reference (aOR = 22.27, 95%CI 7.95-62.40) ( Table 4) . Similarly, frequencies of the Gln/Pro-Arg/Arg genotype were 2% in controls and 12% in lung squamous cell cancer (LSQ) cases, giving rise to an aOR of 10.13 (95% CI 3.29-31.19) and Bonferroni-corrected P = 1.08 £ 10
¡4
. Finally, Gln/Pro-Gln/Gln frequencies were less than 1% in controls and 3% in lung adenocarcinoma (LAD), producing an aOR of 23.99, 3% in LSQ, producing an aOR of 55.08, 2% in head and neck squamous cell carcinoma (HNSCC), producing an aOR of 34.14 and 9% in CRC, producing an aOR of 54.96. (corrected P = 0.045-5.32 £ 10 ¡4 ) Therefore, the small fraction of the population having these rare types of combined genotypes of the two SNPs of PTPRJ exhibited increased risks for certain cancers, the type of cancer depending on the genotype.
PTPN13 genotypes and cancer risk
Single associations
Genotype frequencies of Ile1522Met in control subjects were 37% Ile/Ile, 49% Ile/Met, and 14% Met/Met. We took the heterozygote, Ile/Met, as the reference because it was the most prevalent genotype in control subjects. Because the homozygote major allele, Ile/Ile, was present in 47% of LSQ cases, this genotype showed a high risk of LSQ (aOR = 1.86).
Association with the combined genotypes
When the data of the two SNPs of PTPN13 were analyzed altogether, frequencies of the combined genotypes in controls were 29% Ile/Ile-Tyr/Tyr, 39% Ile/Met-Tyr/Asp, and 32% consisting of all others (Table 3) . Again, taking the most popular genotype in controls, Ile/Met-Tyr/Asp, as the reference, the Ile/Ile-Asp+ genotype exhibited high risks of General associations of the PTP SNPs with all cancer groups.
Because the four SNPs in the two PTP family genes were associated with a wide spectrum of cancers, we evaluated the associations in all cancer cases (n = 569).
Results that were statistically signiWcant after adjustment by age, gender and smoking habit are summarized in Table 6 .
PTPRJ, single associations
At the Arg326Gln SNP, Gln+ genotype exhibited generally high risks for all cancer types examined (aOR = 1.48).
PTPRJ, combined associations
When the Gln276Pro and Arg326Gln were analyzed jointly, the Gln/Gln-Arg/Gln genotype with low prevalence had a very high risk of all cases combined, with an aOR of 5.65. The Gln/Pro-Gln/Gln genotype had an extremely high risk with an aOR of 30.79.
PTPN13, single associations
At the Tyr2081Asp SNP, moderately high risks were found for the homozygous major allele (Tyr/Tyr) when the heterozygote genotype was used as a reference, with aOR = 1.29 for all cancer types combined.
PTPN13, combined associations
Joint risk for the Ile1522Met and Tyr2081Asp were analyzed. When the most prevalent double heterozygote was used as the reference, four other genotypes exhibited a variety of risks for all cancer types combined (Table 6 ). High risks were found for the Ile/Ile-Asp + (aOR = 1.81), Ile/ Met-Tyr/Tyr (aOR = 2.89) and Met/Met-Asp+ (aOR = 6.84) genotypes. Thus, single or combined genotypes of the four missense SNPs in the PTPRJ and PTPN13 genes were variably associated with susceptibility to a wide variety of cancers in the Japanese population. Most notably, the PAF of these associations varied between 9 and 83% (Tables 5, 6 ), which would account for a substantial proportion of the genetic predisposition for these malignancies. However, the actual impact of these PAFs was estimated to be between 9 and 34% based on the variance of the risk distribution due to a single genotype calculated according to the formula (Pharoah et al. 2008 ).
Discussion
In this study, we analyzed SNPs in two genes, PTPRJ and PTPN13. PTPRJ inhibits cell growth by dephosphorylation of ERK1/2 in the MAPK signaling pathway mediated by various growth factors (Massa et al. 2004; Grazia Lampugnani et al. 2003; Kellie et al. 2004; Palka et al. 2003) . In contrast, PTPN13 inhibits apoptosis by dephosphorylation of FAS or by interaction with PRK2 (Erdmann 2003; Ivanov et al. 2006; Gross et al. 2001) , or promotes apoptosis by dephosphorylation of IRS-1 (Abaan and Toretsky 2008) .
We found strong associations of Gln276Pro and/or Arg326Gln genotypes of PTPRJ with susceptibilities to LSQ and CRC. Statistically, the most highly signiWcant results were obtained for CRC (Bonferroni-corrected P = 0.0486-7.20 £ 10 ¡9 ), with a relatively high PAF (between 15 and 83%), and a permutation P value is 1.00 £ 10 ¡4 . With both SNPs, minor alleles (Pro and Gln) were considered to be responsible for the risk. PTPRJ is a likely candidate of the human homologue of the mouse SCC1 and the PTPRJ locus shows a high frequency of LOH in colon, lung, and breast cancers (Ruivenkamp et al. 2002 (Ruivenkamp et al. , 2003 . Our data demonstrate, for the Wrst time, that the SCC1/PTPRJ locus aVects susceptibility to CRC in humans. It is of special interest that, at the polymorphic Gln276Pro, the Gln allele showed preferential loss compared to the Pro allele (Ruivenkamp et al. 2002) . However, in our single association study, the Arg326Gln SNP demonstrated a much closer association with CRC risk than the Gln276Pro SNP. Thus, our data suggest that the incidence of CRC among Japanese is highly inXuenced by the SNPs of the PTPRJ gene, especially by the Arg326Gln SNP.
The Gln276Pro and Arg326Gln polymorphisms of PTPRJ locate on the second FNIII repeat domain of the extracellular portion. The Gln276Pro polymorphism leads to torsional stress and loss of an available hydrogen bond forming group, and the Arg326Gln polymorphism induces loss of positive charge in the domain (Ruivenkamp et al. 2002) . These polymorphisms may therefore induce changes in tertiary structure of the second FNIII repeat domain. PTPRJ is known to be activated by stimuli to its extracellular domain (Takahashi et al. 2006) , and activated PTPRJ suppresses the RAS-RAF-ERK pathway, which normally leads to cell growth by ERK1/2 phosphorylation (Nishimoto and Nishida 2006). It is therefore thought that these polymorphisms have the potential to lead to uncontrolled cell growth through their association with reduced PTPRJ activity as a result of structural changes in the second FNIII domain, which results in activation of the RAS-RAF-ERK pathway and a concomitant increase in phosphorylated ERK1/2. PTPRJ is also an inhibitor of VEGFR2 phosphorylation and as a suppressor of VEGF activity (Grazia Lampugnani et al. 2003) . VEGF functions in angiogenesis, as an important factor in the formation of new vessels during embryogenesis, and in proliferative diseases such as cancer in the adult (Alitalo et al. 2005) . PTPRJ can induce dephosphorylation of not only VEGFR2 but also PDGFR (Kellie et al. 2004 ) and HGFR (Palka et al. 2003) , which are implicated in carcinogenesis. It is therefore suggested that polymorphisms in PTPRJ induce changes in various kinds of growth factor signaling pathways. It has been reported recently that both SNP imbalance and LOH at the PTPRJ region are more prevalent in thyroid carcinoma cases than in cancer-free controls ). Thus, one may postulate that these SNPs are associated with carcinogenesis in many organs. In our study, diVerent combination genotypes of the two SNPs exerted diVerent eVects on the incidence of a variety of cancers. It is thought that particular combination genotypes may induce greater changes in tertiary structure of the second FNIII domain than single SNPs. However, Lesueur did not Wnd any signiWcant association between breast cancer risk and the Gln276Pro polymorphism in the UK (Lesueur et al. 2005 ), although they found that a particular haplotype of PTPRJ led to a reduced risk of breast cancer. We also did not Wnd any signiWcant association of this SNP with risk of LAD and ESCC. Therefore, sensitivity to these polymorphisms may vary among organs.
We found, for the Wrst time, strong associations of some minor genotypes of Ile1522Met and/or Tyr2081Asp SNPs in the PTPN13 gene with susceptibilities to all cancer types we examined except for ESCC. SigniWcant association with single SNP genotype was found only in LSQ, while combinations of the two SNP genotypes gave positive results in LAD, HNSCC, and CRC. In the literature, only one report has shown an association, that being between a PTPN13 SNP and familial hepatoma risk in Taiwan (Yeh et al. 2006) . Statistically, the most highly signiWcant results in our study were obtained for three minor combination genotypes and lung cancers (aOR 3.89-13.75, Bonferroni-corrected P = 0.0468-1.48 £ 10 ¡7 ), with relatively high PAFs (23-56%). It is notable that these high risks were observed when the most prevalent heterozygotes were used as references. When the homozygotes of the major alleles were used as references, most of the results for lung cancer (LAD and LSQ) and CRC were similar to those above, although the adjusted odds ratios decreased slightly. These results suggest that the major allele of each SNP of PTPN13 exhibits higher activity to suppress apoptosis than the minor allele, thereby enhancing cancer risk. Further functional studies are warranted to clarify these issues.
The PTPN13 protein has diverse functions [e.g., inhibition of FAS-mediated apoptosis (Erdmann 2003) ]. Each of the SNPs in PTPN13 resides in the third PDZ domain (Ile1522Met) or in proximity to the phosphatase domain (Tyr2081Asp) (Villa et al. 2005 ). PRK2, a protein that interacts with the third PDZ domain, inhibits apoptosis by suppression of AKT1 activation (Koh et al. 2000) . The second PDZ domain in PTPN13 interacts with FAS and suppresses apoptosis as a result of inhibition of FAS membrane traYcking (Ivanov et al. 2006) . Interestingly, it has been reported that PTPN13 not only interacts with FAS but also dephosphorylates FAS (Foehr et al. 2005) . Thus, we thought that Tyr2081Asp might inXuence the suppressive activity of apoptosis through a change in tertiary structure aVecting either that interaction or dephosphorylation. The PTPN13 expression levels are high in tissues such as lung, testis, kidney, stomach, and skin, but low in other tissues (Cuppen et al. 1997) . DiVerent sensitivities among organs to the polymorphisms may be related to the diVerent expression pattern of these PTPs or their interacting proteins.
In summary, variants of single SNPs or combinations of genotypes of two SNPs in the PTP family genes PTPRJ and PTPN13 appear to confer increased risks of several types of cancer among Japanese (Tables 3, 4, 5) . It is reasonable to postulate that these could be common genetic predisposition factors for many human malignancies. It is also of interest that more profound eVects were seen with combination genotypes than with single polymorphisms alone. According to the NCBI SNP database, frequencies of the minor alleles of each of the two SNPs of PTPRJ and PTPN13 are between 14-27% and 18-42%, respectively, in every ethnic population except persons of African descent. Since the allelic frequencies of these SNPs are common to many human races, it would be worthwhile to verify our Wndings in other populations. However, due to the relatively small scale of our study, further and more in-depth studies on larger samples are deWnitely needed to conWrm our conclusions.
